Puas yog Atosiban yog ib qho tseem ceeb hauv kev tiv thaiv kev yug ntxov ntxov?
Jan 01, 2026
Tso lus
Taw qhia
Qhov Tseem Ceeb ntawm Kev Tswj Xyuas Kev Ua Haujlwm Rau cov tsev neeg ntsib qhov kev pheej hmoo ntawm kev yug menyuam ntxov, txhua hnub ntxiv ntawm kev xeeb tub yog qhov tseem ceeb heev, cuam tshuam ncaj qha rau tus menyuam mos qhov kev mob tshwm sim thiab ntev - kev noj qab haus huv. Hauv kev ua haujlwm ntawm kev tsim menyuam yaus thiab kev yug menyuam, Atosiban, qhov tseem ceeb ntawm lub tsev menyuam contraction inhibitor, tau txais kev saib xyuas thoob ntiaj teb.
Lub npe tshuaj Atosiban sawv cev rau cov tshuaj siv tshuaj kho mob kom ncua kev ua haujlwm ua ntej lub sijhawm ua haujlwm. Nws cov hmoov raw khoom yog nyob rau hauv lub hauv paus ntawm lub ntiaj teb no kws muab saw hlau. Kab lus no yuav siv txoj hauv kev nruj los txhais cov txiaj ntsig kev tshawb fawb, kev siv tshuaj kho mob, thiab cov qauv zoo ntawm nws cov khoom siv raw.
Dab tsi yog Pharmacological Mechanism of Action rau Atosiban?
Lub hauv paus ntsiab lus ntawm kev ua haujlwm ntawmAtosibantuaj yeem nkag siab tias "Kev sib tw Receptor Antagonism."Lub cev "oxytocin" molecule yog lub cim tseem ceeb uas ua rau lub tsev me nyuam contractions. Atosiban yog ib qho hluavtaws peptide uas nws cov qauv molecular zoo ib yam li oxytocin, tso cai rau nws nyiam khi rau oxytocin receptors ntawm lub tsev menyuam cov leeg nqaij. Ua kom lub tsev menyuam ua kom lub cev muaj zog thaum lub sijhawm pib ntawm kev tsim tshuaj, Atosiban muaj nyob rau hauv siab - purity hmoov raw khoom.
Puas yog Atosiban Clinically zoo thiab muaj kev nyab xeeb rau ncua sij hawm gestation?
Yog lawm, nws qhia tau tias muaj kev nyab xeeb thiab kev zam tau zoo piv rau cov kws kho mob zoo sib xws. Lub hom phiaj kho mob ntawm Atosiban tsis yog txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau Cov kev tshawb fawb qhia tias nws feem ntau ncua kev xa khoom tsawg kawg yog 48 teev txog 7 hnub. Lub qhov rais lub sijhawm tseem ceeb no yog qhov tseem ceeb rau kev cuam tshuam kev kho mob. Nws tso cai rau cov kws kho mob muab tshuaj corticosteroids rau tus menyuam hauv plab kom nrawm lub ntsws kom loj tuaj lossis hloov tus niam mus rau qhov chaw kho mob uas muaj qib siab dua -theem neonatal intensive care.
Dab tsi yog Qhov Muaj Peev Xwm Muaj Peev Xwm thiab Kev Mob Phem rau Niam thiab Tus Me Nyuam Tom Qab Siv Atosiban?
Txawm hais tias txhua yam tshuaj cuam tshuam nrog cov metabolism thiab cov kev mob tshwm sim, Atosiban nthuav tawm qhov tsis tshua muaj -profile txaus ntshai.
Rau Niam: Cov kev mob tshwm sim feem ntau pom hauv kev sim tshuaj muaj xws li xeev siab, mob taub hau, thiab qee zaus hypotension. Piv nrog rau cov tshuaj beta ib txwm siv -cov tshuaj agonist (xws li ritodrine), uas tuaj yeem ua rau cov kab mob plawv xws li nce plawv dhia, cov kev mob tshwm sim ntawm leej niam ntawm Atosiban tau txo qis.
Rau Fetus: Atosiban suav tias yog "fetus-tus phooj ywg" tshuaj. Vim nws cov yam ntxwv molecular, qhov ntau uas hla lub placental barrier yog tsawg heev. Cov ntaub ntawv kho mob tam sim no tsis qhia txog qhov ntev - lub sij hawm tsis zoo rau lub plawv dhia, kev loj hlob, lossis qhov hnyav ntawm tus menyuam mos.
Qhov txiaj ntsig zoo li cas Atosiban Tuav Cov Pa Tocolytics (xws li Magnesium Sulfate)?
Atosiban qhia tau hais tias superior Target Specificity hauv inhibiting uterine contractions. Cov txiaj ntsig kev kho mob uas tshwm sim los ntawm qhov kev xaiv no yog pom pom hauv cov lus sib piv hauv qab no:
|
Cov khoom sib piv |
Atosiban (High Selectivity) |
Cov Tshuaj Pas Dej (piv txwv li, Magnesium Sulfate / CCBs) |
|
Mechanism ntawm Action |
Precisely lub hom phiaj oxytocin receptors; kev sib tw antagonism |
Muaj feem xyuam rau cov leeg du thiab cov hlab ntsha systemically; indirect contraction inhibition |
|
Hom phiaj tshwj xeeb |
Siab (Feem ntau ua rau lub tsev menyuam) |
Tsawg (Systemic teebmeem, nrog rau cov hlab plawv system) |
|
Niam Txiv Tsis Zoo |
Kev pheej hmoo qis dua: xeev siab me ntsis, mob taub hau, ntuav hypotension |
Kev pheej hmoo siab dua: tachycardia, kub flashes, toxicity, electrolyte cuam tshuam, thiab lwm yam. |
|
Kev tsim nyog rau cov neeg tshwj xeeb |
Kev siv dav dua, tshwj xeeb tshaj yog rau cov neeg mob uas muaj co- mob plawv plawv |
Yuav tsum tau ceev faj; nce kev pheej hmoo rau siab - cov neeg mob plawv |
|
Lub Hom Phiaj Kho Mob |
Tau 48 teev mus rau 7 hnub rau kev loj hlob ntawm tus menyuam hauv plab |
Tau txais lub sijhawm rau fetal ntsws maturation |
Gestational Stage twg yog qhov zoo tshaj plaws rau kev siv Atosiban, thiab Puas muaj sij hawm nruj?
Daim ntawv thov ntawm Atosiban yuav tsum nruj me ntsis ua raws li Gestational Age Limitations. Nws feem ntau yog siv los ntawm 24 thiab 33 lub lis piam ntawm cev xeeb tub thaum muaj cov tsos mob ntawm kev ua haujlwm tsis zoo, xws li kev cog lus tsis tu ncua thiab kev hloov ntawm ncauj tsev menyuam, tam sim no.
Ua ntej 24 lub lis piam: fetal viability yog tsawg heev nyob rau theem no, thiab cov tshuaj pharmacological cuam tshuam qhia tau hais tias tsis muaj kev ua tau zoo.
Tom qab 34 lub lis piam: Kev loj hlob ntawm fetal ntsws yog loj hlob. Kev txuas txuas ntxiv inhibition nyob rau theem no feem ntau ua rau muaj kev pheej hmoo tsawg dua - qhov txiaj ntsig zoo, thiab kev kho mob feem ntau tsis pom zoo.
Atosiban puas tuaj yeem ua kev pabcuam ntxiv hauv Vitro Fertilization (IVF) Embryo Transfer?
Yog, cov kev tshawb fawb ntsig txog tam sim no tshawb nrhiav daim ntawv thov no. Thaum lub sij hawm IVF-Cov txheej txheem Hloov Embryo, qee tus poj niam yuav muaj kev cuam tshuam uterine ntau zaus uas tuaj yeem cuam tshuam txog kev cog qoob loo. Kev soj ntsuam kev soj ntsuam txwv tsis pub qhia tias siv Atosiban ib puag ncig lub sijhawm hloov embryo tuaj yeem pab txo qis tsis yog - lub cev nqaij daim tawv nqaij contractions, yog li muaj peev xwm txhim kho qhov chaw cog qoob loo thiab txhim kho kev ua tiav. Txawm li cas los xij, qhov no tseem yog thaj chaw tshawb nrhiav thiab tseem tsis tau dhau los ua tus txheej txheem kev kho mob thoob ntiaj teb.
Txij li thaum Atosiban Powder yog Raw Material, nws puas tso cai rau cov pej xeem siv nws tus kheej?
Qhov kev txiav txim no yog txwv nruj heev thiab txaus ntshai heev. Cov "Atosiban hmoov" tham txog yog Active Pharmaceutical Ingredient (API) npaj rau kev yuav khoom los ntawm cov kws tshaj lij kws tsim tshuaj.
• Formulation Conversion:Cov hmoov yuav tsum tau ua raws li qhov hnyav, kev sib cais, thiab kev tsim ua kom tsis muaj menyuam, GMP (Good Manufacturing Practice) ib puag ncig kom hloov mus rau hauv cov tshuaj Intravenous uas ua tau raws li tib neeg cov qauv kev txhaj tshuaj.
• Clinical Administration:Cov tshuaj yuav tsum tau muab los ntawm kev txhaj tshuaj intravenously siv cov cuab yeej hauv tsev kho mob, nrog rau cov tshuaj infusion thiab ntau npaum li cas tswj hwm los ntawm cov kws kho mob uas tau kawm. Cov pej xeem tsis tuaj yeem tswj hwm tus txheej txheem tsim kom muaj kev nyab xeeb. Kev siv ywj pheej lossis kev sib cuag nrog cov hmoov nyoos tuaj yeem ua rau muaj kab mob, kev siv tshuaj tsis raug, thiab teeb meem kev nyab xeeb hnyav.
Vim li cas qhov Purity ntawm Atosiban Raw Material yog qhov tseem ceeb tshaj plaws rau kev ruaj ntseg tshuaj?
Raw khoom purity yog ib qho tseem ceeb qhia qhov zoo rau kev lag luam kws tshuaj thiab qhov kawg kev nyab xeeb kev kho mob. Raws li ib tug complex peptide tshuaj, Atosiban synthesis nkag tau cov khoom byproducts thiab structurally zoo impurities.High -cov ntaub ntawv raw khoom(piv txwv li, 98% lossis siab dua) qhia cov ntsiab lus tsis huv tsawg. Yog tias cov impurities no dhau qhov tsim nyog, lawv tuaj yeem tsis tsuas yog txo qhov kev ua tau zoo ntawm qhov kawg formulation tab sis kuj muaj peev xwm ua rau lub cev tiv thaiv kab mob, kev ua xua, lossis lwm yam teeb meem tsis zoo hauv kev siv tshuaj kho mob. Yog li ntawd, cov tuam txhab tshuaj siv cov kev xav tau nruj heev ntawm API purity.
Vim li cas cov neeg tsim khoom tseem ceeb "Xi'an Tihealth" Thaum Sourcing Siab -Purity Atosiban Raw Khoom?
Nyob rau hauv lub ntiaj teb no khoom lag luam rauAtosibanHmoov,Xi'an Tihealth Biotechnology Co., Ltd.tau lees paub tias yog tus xa khoom tseem ceeb vim nws cov kws tshaj lij tshwj xeeb.
Lawv cov txiaj ntsig kev sib tw tseem ceeb nyob hauv kev tswj hwm nruj tshaj peptide tshuaj ntau lawm:
• High Purity thiab Stability:Lawv tsis tu ncua tsim cov ntaub ntawv raw nrog purity theem siab tshaj 98%, kom ntseeg tau qhov zoo ntawm cov tshuaj nquag thiab muab cov khoom lag luam ruaj khov.
• International Standard Compliance:Cov txheej txheem tsim khoom nruj me ntsis ua raws li kev lees paub thoob ntiaj teb GMP kev tswj hwm zoo. Lub tuam txhab muab cov ntaub ntawv txheeb xyuas dav dav (COA), High-Kev Ua Haujlwm Liquid Chromatography (HPLC), thiab Mass Spectrometry (MS) cov ntaub ntawv, uas ua kom yooj yim rau kev sau npe tshuaj thoob ntiaj teb thiab R&D cov dej num.
• Kev Muaj Peev Xwm Kev Pabcuam:Lawv tuaj yeem ua tau raws li ob qho me me - ntsuas qhov kev xav tau rau cov chaw tshawb fawb thiab loj - cov kev xav tau ntawm kev tsim khoom lag luam rau cov tuam txhab tshuaj, ua kom muaj kev sib koom ua ke thoob plaws hauv cov khoom siv.
Rau kev yuav khoom thiab R&D cov kws tshaj lij nrhiav kev ua haujlwm siab -cov ntaub ntawv zoo, traceable raw cov ntaub ntawv, qhov no yog lub ntsiab lus tseem ceeb ntawm kev siv rau kev ntsuam xyuas tus neeg muag khoom.
Cov ntaub ntawv
1. European Medicines Agency. Atosiban: Assessment Report (2014).
2. Romero R, et al. Lub luag haujlwm ntawm atosiban hauv kev tswj hwm kev ua haujlwm ua ntej. Obstetrics & Gynecology International, 2012.
3. Tocolytics rau kev yug ntxov ntxov: Cochrane Database of Systematic Reviews. (Saib xyuas tsom mus rau kev sib piv kev ua tau zoo).
4. Westgate JA, et al. Atosiban pharmacology thiab kev nyab xeeb profile. Kws Tshaj Lij Tshaj Tawm Txog Kev Nyab Xeeb Tshuaj, 2011.
5. Nishikawa H, et al. Kev soj ntsuam kev soj ntsuam ntawm atosiban hauv kev hem thawj ua haujlwm ua ntej. Phau ntawv Journal of Obstetrics thiab Gynecology Research, 2016.
(Tsis lees paub: Kab lus no yog tsim los rau cov ntaub ntawv xov xwm thiab kev paub txog kev lag luam nkaus xwb, thiab tsis yog cov lus qhia txog kev kho mob. Txhua qhov kev txiav txim siab txog kev siv tshuaj yuav tsum tau ua raws li kev taw qhia ntawm tus kws kho mob tsim nyog.)
Xa kev nug